Our findings propose that the rare variants in two potential candidate genes (IL1R1 and CD3E) identified in this study are likely to contribute to gluten insensitivity and CeD pathogenesis by modulating the T-cell selection and maturation, cytokine signaling, and adaptive immune response pathways. The gene discussed is CD3E; the disease is cranioectodermal dysplasia.